Eli Lilly and Company Reports Strong Financial Results

Key Financial Metrics Show Continued Growth

Indianapolis, IN - May 22, 2023 - Eli Lilly and Company (NYSE: LLY) today announced its financial results for the first quarter of 2023. The company reported strong revenue growth, driven by increased demand for its core products and new product launches.

Revenue and Earnings

Total revenue for the quarter was $6.5 billion, an increase of 10% compared to the same period last year. This growth was led by strong sales of the company's diabetes, oncology, and immunology drugs. Net income for the quarter was $1.8 billion, up from $1.5 billion in Q1 2022.

Eli Lilly's financial results were in line with analysts' expectations and demonstrate the company's ongoing commitment to innovation and growth.